Related Experiment Video
Updated: Apr 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative
Dandan Liu1, Yingye Zheng2, Ross L Prentice2
1Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232.
Abstract:
Accurate and individualized risk prediction is critical for population control of chronic diseases such as cancer and cardiovascular disease. Large cohort studies provide valuable resources for building risk prediction models, as the risk factors are collected at the baseline and subjects are followed over time until disease occurrence or termination of the study. However, for rare diseases the baseline risk may not be estimated reliably based on cohort data only, due to sparse events. In this paper, we propose to make use of external information to improve efficiency for estimating time-dependent absolute risk. We derive the relationship between external disease incidence rates and the baseline risk, and incorporate the external disease incidence information into estimation of absolute risks, while allowing for potential difference of disease incidence rates between cohort and external sources. The asymptotic properties, namely, uniform consistency and weak convergence, of the proposed estimators are established. Simulation results show that the proposed estimator for absolute risk is more efficient than that based on the Breslow estimator, which does not utilize external disease incidence rates. A large cohort study, the Women's Health Initiative Observational Study, is used to illustrate the proposed method.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Hazard Rate
Kaplan-Meier Approach
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...

